| Primary |
| Crohn's Disease |
22.0% |
| Colitis Ulcerative |
9.8% |
| Renal Transplant |
7.3% |
| Systemic Lupus Erythematosus |
7.3% |
| Liver Transplant |
6.1% |
| Rheumatoid Arthritis |
6.1% |
| Foetal Exposure During Pregnancy |
4.9% |
| Immunosuppressant Drug Therapy |
4.9% |
| Product Used For Unknown Indication |
4.9% |
| Drug Use For Unknown Indication |
3.7% |
| Overlap Syndrome |
3.7% |
| Systemic Sclerosis |
3.7% |
| Hiv Infection |
2.4% |
| Immunosuppression |
2.4% |
| Interstitial Lung Disease |
2.4% |
| Lung Transplant |
2.4% |
| Myasthenia Gravis |
2.4% |
| Acute Graft Versus Host Disease In Skin |
1.2% |
| Antifungal Prophylaxis |
1.2% |
| Autoimmune Hepatitis |
1.2% |
|
| Septic Shock |
11.5% |
| Crohn's Disease |
7.7% |
| Kaposi's Sarcoma |
7.7% |
| Osteomyelitis |
7.7% |
| Thrombocytopenia |
7.7% |
| Acute Lymphocytic Leukaemia |
3.8% |
| Alopecia |
3.8% |
| Cerebral Aspergillosis |
3.8% |
| Communication Disorder |
3.8% |
| Convulsion |
3.8% |
| Deafness Neurosensory |
3.8% |
| Drug Ineffective |
3.8% |
| Encephalitis |
3.8% |
| Enterococcal Infection |
3.8% |
| Foetal Exposure During Pregnancy |
3.8% |
| Hepatic Haemorrhage |
3.8% |
| Hepatitis C |
3.8% |
| Hepatomegaly |
3.8% |
| Jaundice Cholestatic |
3.8% |
| Lethargy |
3.8% |
|
| Secondary |
| Crohn's Disease |
26.6% |
| Drug Use For Unknown Indication |
9.2% |
| Immunosuppression |
9.2% |
| Product Used For Unknown Indication |
7.3% |
| Colitis Ulcerative |
6.4% |
| Polymyositis |
4.9% |
| Renal Transplant |
4.7% |
| Behcet's Syndrome |
4.1% |
| Rheumatoid Arthritis |
3.7% |
| Dermatomyositis |
3.1% |
| Pemphigus |
3.1% |
| Immunosuppressant Drug Therapy |
2.4% |
| Prophylaxis Against Transplant Rejection |
2.3% |
| Idiopathic Thrombocytopenic Purpura |
2.1% |
| Juvenile Arthritis |
2.1% |
| Hypertension |
2.0% |
| Systemic Lupus Erythematosus |
2.0% |
| Wegener's Granulomatosis |
2.0% |
| Cryoglobulinaemia |
1.5% |
| Leukocytoclastic Vasculitis |
1.4% |
|
| Neutropenia |
14.0% |
| Renal Cell Carcinoma |
8.1% |
| Hodgkin's Disease |
5.8% |
| Pancytopenia |
5.8% |
| Pneumocystis Jiroveci Pneumonia |
5.8% |
| Pyrexia |
5.8% |
| Squamous Cell Carcinoma |
5.8% |
| Tumour Lysis Syndrome |
5.8% |
| Cytomegalovirus Infection |
4.7% |
| Urethral Valves |
4.7% |
| Anaemia |
3.5% |
| Crohn's Disease |
3.5% |
| Drug Exposure During Pregnancy |
3.5% |
| Intermediate Uveitis |
3.5% |
| Pneumonia |
3.5% |
| Pregnancy |
3.5% |
| Thrombosis |
3.5% |
| Transplant Rejection |
3.5% |
| Visual Impairment |
3.5% |
| Cytomegalovirus Enterocolitis |
2.3% |
|
| Concomitant |
| Crohn's Disease |
34.5% |
| Colitis Ulcerative |
9.6% |
| Product Used For Unknown Indication |
8.2% |
| Drug Use For Unknown Indication |
7.9% |
| Rheumatoid Arthritis |
6.2% |
| Renal Transplant |
4.9% |
| Heart Transplant |
3.2% |
| Pain |
2.7% |
| Inflammatory Bowel Disease |
2.4% |
| Premedication |
2.4% |
| Prophylaxis |
2.4% |
| Renal Failure Chronic |
2.2% |
| Depression |
1.9% |
| Tremor |
1.9% |
| Wegener's Granulomatosis |
1.9% |
| Osteoporosis |
1.7% |
| Gastric Disorder |
1.6% |
| Hypertension |
1.6% |
| Drug Exposure During Pregnancy |
1.4% |
| Hypovitaminosis |
1.4% |
|
| Crohn's Disease |
16.5% |
| Tuberculosis |
10.3% |
| Pyrexia |
8.2% |
| Ischaemia |
6.2% |
| Erythema Nodosum |
5.2% |
| Retinal Vein Thrombosis |
5.2% |
| Infusion Related Reaction |
4.1% |
| Intestinal Obstruction |
4.1% |
| Psoriasis |
4.1% |
| Swelling |
4.1% |
| Urinary Tract Infection |
4.1% |
| Breast Cancer |
3.1% |
| Cardiac Failure |
3.1% |
| Colitis Ulcerative |
3.1% |
| Drug Ineffective |
3.1% |
| Lipase Increased |
3.1% |
| Osteonecrosis |
3.1% |
| Protein Urine Present |
3.1% |
| Pulmonary Embolism |
3.1% |
| Rash |
3.1% |
|
| Interacting |
| Product Used For Unknown Indication |
84.6% |
| Muscular Weakness |
5.8% |
| Analgesic Therapy |
1.9% |
| Benign Prostatic Hyperplasia |
1.9% |
| Pain |
1.9% |
| Prophylaxis |
1.9% |
| Tooth Infection |
1.9% |
|
| Agranulocytosis |
50.0% |
| Diarrhoea |
50.0% |
|
